These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The limbic system in Alzheimer's disease. A neuropathologic investigation. Hopper MW; Vogel FS Am J Pathol; 1976 Oct; 85(1):1-20. PubMed ID: 135514 [TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease: a multisystem disorder. Price DL; Struble RG; Whitehouse PJ; Kitt CA; Cork LC; Walker LC; Casanova MF Res Publ Assoc Res Nerv Ment Dis; 1986; 64():209-14. PubMed ID: 3523660 [No Abstract] [Full Text] [Related]
7. Significance of neurotransmitter abnormalities in Alzheimer's disease. Katzman R; Brown T; Fuld P; Thal L; Davies P; Terry R Res Publ Assoc Res Nerv Ment Dis; 1986; 64():279-86. PubMed ID: 2873637 [No Abstract] [Full Text] [Related]
8. Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease. Rylett RJ; Ball MJ; Colhoun EH Brain Res; 1983 Dec; 289(1-2):169-75. PubMed ID: 6661641 [TBL] [Abstract][Full Text] [Related]
9. The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease. Mesulam MM Prog Brain Res; 1996; 109():285-97. PubMed ID: 9009717 [No Abstract] [Full Text] [Related]
10. High-affinity choline uptake carrier in Alzheimer's disease: implications for the cholinergic hypothesis of dementia. Pascual J; Fontán A; Zarranz JJ; Berciano J; Flórez J; Pazos A Brain Res; 1991 Jun; 552(1):170-4. PubMed ID: 1913175 [TBL] [Abstract][Full Text] [Related]
11. A case of Alzheimer's disease and hippocampal sclerosis with normal cholinergic activity in basal forebrain, neocortex, and hippocampus. Zweig RM; Schegg KM; Peacock JH; Melarkey D Neurology; 1989 Feb; 39(2 Pt 1):288-90. PubMed ID: 2915803 [TBL] [Abstract][Full Text] [Related]
12. Acetylcholine and choline levels in post-mortem human brain tissue: preliminary observations in Alzheimer's disease. Richter JA; Perry EK; Tomlinson BE Life Sci; 1980 May; 26(20):1683-9. PubMed ID: 7392805 [No Abstract] [Full Text] [Related]
13. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. Modrego PJ; Fayed N; Pina MA Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137 [TBL] [Abstract][Full Text] [Related]
14. Do raised brain aluminium levels in Alzheimer's dementia contribute to cholinergic neuronal deficits? King RG Med Hypotheses; 1984 Jul; 14(3):301-6. PubMed ID: 6472159 [TBL] [Abstract][Full Text] [Related]
15. Choline in Alzheimer's disease. Spillane JA; Goodhart MJ; White P; Bowen DM; Davison AN Lancet; 1977 Oct; 2(8042):826-7. PubMed ID: 71636 [No Abstract] [Full Text] [Related]
16. Alterations of signal transduction in the lesioned entorhinal-hippocampal system: a mini-review on Alzheimer's disease-related changes and experimental data. Ohm TG Hippocampus; 1993; 3 Spec No():131-8. PubMed ID: 8287091 [No Abstract] [Full Text] [Related]
17. Dementia of the Alzheimer type. Terry RD; Davies P Annu Rev Neurosci; 1980; 3():77-95. PubMed ID: 6251745 [No Abstract] [Full Text] [Related]
18. Presynaptic cholinergic dysfunction in patients with dementia. Sims NR; Bowen DM; Allen SJ; Smith CC; Neary D; Thomas DJ; Davison AN J Neurochem; 1983 Feb; 40(2):503-9. PubMed ID: 6822833 [TBL] [Abstract][Full Text] [Related]
19. A disorder of cortical GABAergic innervation in Alzheimer's disease. Hardy J; Cowburn R; Barton A; Reynolds G; Dodd P; Wester P; O'Carroll AM; Lofdahl E; Winblad B Neurosci Lett; 1987 Jan; 73(2):192-6. PubMed ID: 3822251 [TBL] [Abstract][Full Text] [Related]
20. Glial intranuclear inclusion bodies in a patient with Alzheimer's disease. al-Maghrabi J; Tierney M; Ang LC Acta Neuropathol; 2000 Jun; 99(6):695-8. PubMed ID: 10867805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]